Biometrics CRO Cytel expands offerings
Cytel has expanded its footprint in Europe, further adding to its big data capabilities and “more traditional” contact research services.
Cytel has expanded its footprint in Europe, further adding to its big data capabilities and “more traditional” contact research services.
The US FDA has issued a complete response letter for Sanofi and Regeneron’s rheumatoid arthritis candidate sarilumab due to manufacturing deficiencies at a fill/finish plant in France.
Significant differences in large molecule clinical trials highlights the need to be more efficient, according to a recent analysis of clinical trial duration.
BASF will increase the European sales prices for its ethanolamines by €100 ($110) per metric ton due to the rising costs of the raw material.
The “double edged sword” of increased regulation is a challenge, but Envigo expects outsourcing to continue as the company looks to diversity its service portfolio.
Paid for and content provided by World Courier
Once deficiencies in the supply chain are identified, how can the pharmaceutical industry ensure it manages product quality, consumer safety and organizational risk?